Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Current readings: pathology, prognosis, and lung cancer.

Suh JH.

Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):14-21. doi: 10.1053/j.semtcvs.2013.01.003. Review.

PMID:
23800525
2.

The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H, Weichert W.

J Clin Oncol. 2012 May 1;30(13):1438-46. doi: 10.1200/JCO.2011.37.2185. Epub 2012 Mar 5.

PMID:
22393100
3.

Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.

Song Z, Zhu H, Guo Z, Wu W, Sun W, Zhang Y.

Eur J Surg Oncol. 2013 Nov;39(11):1262-8. doi: 10.1016/j.ejso.2013.08.026. Epub 2013 Sep 11.

PMID:
24063970
4.

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW, Travis WD.

Mod Pathol. 2011 May;24(5):653-64. doi: 10.1038/modpathol.2010.232. Epub 2011 Jan 21.

6.

The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Eguchi T, Kadota K, Park BJ, Travis WD, Jones DR, Adusumilli PS.

Semin Thorac Cardiovasc Surg. 2014 Autumn;26(3):210-22. doi: 10.1053/j.semtcvs.2014.09.002. Epub 2014 Sep 16.

7.

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D.

J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221. Review.

9.

The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.

Westaway DD, Toon CW, Farzin M, Sioson L, Watson N, Brady PW, Marshman D, Mathur MM, Gill AJ.

Pathology. 2013 Oct;45(6):553-8. doi: 10.1097/PAT.0b013e32836532ae.

PMID:
24018816
10.

Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.

Hung JJ, Yeh YC, Jeng WJ, Wu KJ, Huang BS, Wu YC, Chou TY, Hsu WH.

J Clin Oncol. 2014 Aug 1;32(22):2357-64. doi: 10.1200/JCO.2013.50.1049. Epub 2014 May 5.

PMID:
24799473
11.

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Powell CA, Beer D, Riely G, Garg K, Austin JH, Rusch VW, Hirsch FR, Jett J, Yang PC, Gould M; American Thoracic Society.

Proc Am Thorac Soc. 2011 Sep;8(5):381-5. doi: 10.1513/pats.201107-042ST.

PMID:
21926387
12.

The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma.

Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G.

Ann Thorac Surg. 2014 Aug;98(2):453-8. doi: 10.1016/j.athoracsur.2014.04.108. Epub 2014 Jun 21.

PMID:
24961844
13.

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.

Sun Y, Yu X, Shi X, Hong W, Zhao J, Shi L.

World J Surg Oncol. 2014 May 19;12:148. doi: 10.1186/1477-7819-12-148.

14.

Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases.

Woo T, Okudela K, Mitsui H, Tajiri M, Yamamoto T, Rino Y, Ohashi K, Masuda M.

Pathol Int. 2012 Dec;62(12):785-91. doi: 10.1111/pin.12016.

PMID:
23252867
15.

New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.

Travis WD, Brambilla E, Riely GJ.

J Clin Oncol. 2013 Mar 10;31(8):992-1001. doi: 10.1200/JCO.2012.46.9270. Epub 2013 Feb 11. Review.

PMID:
23401443
16.
17.

Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Ishikawa Y, Wistuba I, Flieder DB, Franklin W, Gazdar A, Hasleton PS, Henderson DW, Kerr KM, Nakatani Y, Petersen I, Roggli V, Thunnissen E, Tsao M.

Arch Pathol Lab Med. 2013 May;137(5):685-705. doi: 10.5858/arpa.2012-0264-RA. Epub 2012 Sep 12.

PMID:
22913371
18.

Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.

Yang F, Chen K, Liao Y, Li X, Sun K, Bao D, Wang J.

World J Surg Oncol. 2014 Sep 13;12:285. doi: 10.1186/1477-7819-12-285.

19.

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.

Yeh YC, Kadota K, Nitadori J, Sima CS, Rizk NP, Jones DR, Travis WD, Adusumilli PS.

Eur J Cardiothorac Surg. 2016 Jan;49(1):e9-e15. doi: 10.1093/ejcts/ezv316. Epub 2015 Sep 15.

20.

Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.

Mäkinen JM, Laitakari K, Johnson S, Mäkitaro R, Bloigu R, Lappi-Blanco E, Kaarteenaho R.

Lung Cancer. 2015 Dec;90(3):568-74. doi: 10.1016/j.lungcan.2015.10.014. Epub 2015 Oct 17.

PMID:
26506915

Supplemental Content

Support Center